Brian Canann is a Principal focused on growth-stage investments and small leveraged buyouts in the U.S. medical device, health IT and health service sectors. He is based in Washington, DC.
Mr. Canann has 12 years of operating and investing experience with medical companies. He joined Carlyle in 2004 from Medtronic, where he was the marketing lead for the Endeavor drug-eluting stent development program. Mr. Canann previously worked in the critical care division of Edwards Lifesciences in strategic planning and global product management. He was also a CPA in the Boston office of Price Waterhouse.
Mr. Canann is on the Board of Directors of Carefx Inc., The HealthCentral Network, Inc., Ocular Optics, Inc. and Primary Health, Inc. He is a Board Observer of AqueSys, Inc., PixelOptics, Inc. and Endius, Inc. (sold to Zimmer, Inc.). He also serves on the Cleveland Clinic Industrial Advisory Board. Mr. Canann received an M.S. and B.S. in accounting from Brigham Young University and an M.B.A. from Harvard Business School.